Semaglutide (Wegovy) for the treatment of obesity or weight management should not be used during pregnancy because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm due to the potential hazard of maternal weight loss to the fetus
Pontes HA, Neto NC, Ferreira KB, Fonseca FP, Vallinoto GM, Pontes FS, Pinto Ddos S Jr
We're talking about optimizing research potential, reducing redundancy, and ultimately, accelerating discoveries in areas like Metabolic & Weight Research and Mitochondrial Research
Serious complications are extremely rare
Easy process Great product, it makes me feel better with more energy, and helps to keep my weight just where I want it